Par Drugs & Chemical P/E Ratio
Current P/E Ratio
8.59
Low Valuation
Very Low - Potentially undervalued or facing challenges
Par Drugs & Chemical (PAR) P/E ratio is 8.59 (Low), EPS (TTM) ₹10.65, current price ₹101.33 on NSE — Very Low - Potentially undervalued or facing challenges. Read PAR dividend history for the complete payout history and dividend yield track record.
Current Valuation Metrics
P/E Ratio
8.59
Current Price
₹101.33
EPS (TTM)
₹10.65
Exchange
NSE
Valuation Signal
Signal
Undervalued
Sector Context
Sector Average
54.86
Sector Median
30.43
Sector Rank
#11 of 197
Sector Percentile
5.6%
PAR P/E Ratio — Valuation Signal & Historical Context
Par Drugs & Chemical P/E 8.59 — signal: Undervalued. For live price, revenue and the complete fundamental profile, see PAR screener.
- Stock appears undervalued with PE of 8.59, suggesting potential buying opportunity
- Trading at discount to sector average PE of 54.86
PAR vs Healthcare Peers — P/E Ratio Comparison
Par Drugs & Chemical P/E 8.59 vs Healthcare average 54.86, median 30.43 — range 2.86–706.0.
Sector Average
54.86
Sector Median
30.43
Lowest P/E
2.86
Highest P/E
706.0
Companies
197
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.29 | ₹53 | Low |
| Colinz Laboratories | COLINZ | 3.6 | ₹10 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.05 | ₹6,404 | Low |
| Sunrest Lifescience | SUNREST | 4.19 | ₹67 | Low |
| Shelter Pharma | SHELTER | 4.99 | ₹46 | Low |
| JFL Life Sciences | JFLLIFE | 5.83 | ₹78 | Low |
| GKB Ophthalmics | GKB | 5.94 | ₹33 | Low |
| Dipna Pharmachem | DPL | 6.52 | ₹18 | Low |
| Royal Sense | ROYAL | 6.73 | ₹48 | Low |